AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Issue

Thursday, December 19, 2019


In The News


A rapid five-biomarker assay for sepsis in development for more than a decade classified severity of infection and predicted mortality risk in more than 400 pediatric patients. When adapted to mouse models, this blood test reliably predicted mortality risk and revealed that those with a higher risk for mortality had…
A long-running genome project in the United Kingdom is reporting that whole genome sequencing (WGS) performs with high accuracy in detecting a variety of cancer biomarkers in the human genome, compared with standard methods. For cancer research, this study shows the first steps toward populationwide WGS with clinical reporting, Jason…

AACC Alert


From Singapore and Macon, Georgia to La Plata, Argentina and Livermore, California, AACC members share common sentiments about what drew them to the association and why they continue as members.

Inside AACC


2019’s top five most viewed articles in Clinical Chemistry highlight the new and now, addressing key cardiac biomarkers, a mass spectrometry pen’s ability to identify ovarian cancer tissue, revelations on men’s health and miscarriages, and a novel test for determining single-base methylation. The top five articles appeared in the journal…
The top five most read articles of 2019 in The Journal of Applied Laboratory Medicine (JALM) touched on a broad range of topics, including the growing importance of procalcitonin (PCT) as a sepsis marker, a novel approach for detecting bloodborne pathogens, and challenges that phlebotomists face in performing blood draws…

World View


New guidance urges Canadian physicians to rethink their practices on assessing and treating routine thyroid dysfunction. Studying the benefits, harms, and costs of treating asymptomatic adults with abnormal thyroid stimulating hormone (TSH) tests, the Canadian Task Force on Preventive Health Care asserts that treatment for screen-detected hypothyroidism would do little…